Found: 2
Select item for more details and to access through your institution.
Potential for Pharmacokinetic Interactions Between Ambrisentan and Cyclosporine.
- Published in:
- Clinical Pharmacology & Therapeutics, 2010, v. 88, n. 4, p. 513, doi. 10.1038/clpt.2010.120
- By:
- Publication type:
- Article
An Integrated Pharmacokinetic/Pharmacodynamic (PK/PD) Model For SB-480848 Inhibition of Plasma Lipoprotein-Associated Phospholipase A2 (LP-PLA2) Enzyme Activity in Human.
- Published in:
- Clinical Pharmacology & Therapeutics, 2003, v. 73, n. 2, p. P86, doi. 10.1016/S0009-9236(03)90672-2
- By:
- Publication type:
- Article